SG Americas Securities
NVO

SG Americas Securities’s Novo Nordisk NVO Stock Holding History

SG Americas Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.1M Sell
439,134
-32,990
-7% -$1.42M 0.01% 585
2026
Q1 		$17.4M Sell
472,124
-2,063,222
-81% -$97.8M 0.02% 597
2025
Q4 		$129M Buy
2,535,346
+152,170
+6% +$7.78M 0.16% 93
2025
Q3 		$132M Buy
2,383,176
+2,274,925
+2,102% +$133M 0.45% 25
2025
Q2 		$7.47M Sell
108,251
-5,422
-5% -$369K 0.03% 370
2025
Q1 		$7.89M Buy
113,673
+5,948
+6% +$491K 0.03% 363
2024
Q4 		$9.27M Buy
107,725
+85,272
+380% +$9.22M 0.04% 234
2024
Q3 		$2.67M Sell
22,453
-30,554
-58% -$4.07M 0.01% 576
2024
Q2 		$7.57M Sell
53,007
-400,273
-88% -$53M 0.04% 400
2024
Q1 		$58.2M Buy
453,280
+315,191
+228% +$37.5M 0.28% 64
2023
Q4 		$14.3M Buy
+138,089
New +$13.7M 0.13% 147
2023
Q2 		– Sell
-106,836
Closed -$8.5M – 2898
2023
Q1 		$8.5M Buy
106,836
+74,606
+231% +$5.29M 0.1% 155
2022
Q4 		$2.18M Buy
+32,230
New +$1.89M 0.03% 533
2022
Q2 		– Sell
-12,206
Closed -$678K – 3537
2022
Q1 		$678K Sell
12,206
-5,054
-29% -$259K 0.01% 1693
2021
Q4 		$967K Buy
17,260
+11,128
+181% +$603K 0.01% 1673
2021
Q3 		$294K Buy
+6,132
New +$296K ﹤0.01% 2959
2021
Q2 		– Sell
-6,738
Closed -$227K – 3115
2021
Q1 		$227K Buy
+6,738
New +$240K ﹤0.01% 2596
2020
Q2 		– Sell
-136,578
Closed -$4.11M – 3802
2020
Q1 		$4.11M Buy
136,578
+126,852
+1,304% +$3.78M 0.04% 453
2019
Q4 		$281K Sell
9,726
-10,004
-51% -$277K ﹤0.01% 2241
2019
Q3 		$510K Hold
19,730
– – ﹤0.01% 1872
2019
Q2 		$504K Buy
+19,730
New +$488K ﹤0.01% 1888
2019
Q1 		– Sell
-23,462
Closed -$540K – 3538
2018
Q4 		$540K Buy
+23,462
New +$521K ﹤0.01% 1815
2018
Q2 		– Sell
-26,970
Closed -$664K – 3486
2018
Q1 		$664K Sell
26,970
-14,768
-35% -$388K 0.01% 1677
2017
Q4 		$1.12M Buy
+41,738
New +$1.06M 0.01% 1300
2017
Q3 		– Sell
-87,600
Closed -$1.88M – 3668
2017
Q2 		$1.88M Sell
87,600
-41,224
-32% -$832K 0.02% 939
2017
Q1 		$2.21M Buy
128,824
+19,412
+18% +$338K 0.02% 832
2016
Q4 		$1.96M Sell
109,412
-30,390
-22% -$551K 0.02% 915
2016
Q3 		$2.91M Buy
139,802
+90,302
+182% +$2.24M 0.03% 546
2016
Q2 		$1.33M Buy
49,500
+34,244
+224% +$939K 0.01% 1113
2016
Q1 		$413K Sell
15,256
-171,304
-92% -$4.59M ﹤0.01% 1845
2015
Q4 		$5.42M Buy
186,560
+121,338
+186% +$3.36M 0.04% 360
2015
Q3 		$1.77M Buy
65,222
+48,476
+289% +$1.37M 0.01% 658
2015
Q2 		$459K Buy
16,746
+10,964
+190% +$308K ﹤0.01% 1514
2015
Q1 		$154K Buy
+5,782
New +$133K ﹤0.01% 2033

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

SG Americas Securities's NVO Position: Q2 2026 in Review

SG Americas Securities reduced its Novo Nordisk (NVO) stake by 7% in Q2 2026, selling an estimated $1.42M and leaving 439,134 shares worth $21.1M. The position accounts for 0.01% of the portfolio, ranked #585.

SG Americas Securities first reported a position in NVO in Q1 2015 and has held it in 34 quarters since. The position peaked at $132M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • SG Americas Securities held 439,134 shares of Novo Nordisk worth $21.1M as of Q2 2026.
  • SG Americas Securities sold 32,990 Novo Nordisk shares in Q2 2026, an estimated $1.42M.
  • Novo Nordisk made up 0.01% of SG Americas Securities's portfolio in Q2 2026, its #585 holding.
  • SG Americas Securities first reported a position in Novo Nordisk in Q1 2015 and has held it in 34 quarters since.
  • SG Americas Securities's Novo Nordisk position peaked at $132M in Q3 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.